Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic
Market Cap
$628.09 Million
CN¥4.61 Billion CNY
Market Cap Rank
#12264 Global
#3030 in China
Share Price
CN¥7.41
Change (1 day)
+0.54%
52-Week Range
CN¥6.16 - CN¥8.03
All Time High
CN¥16.21
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, an… Read more

Jinling Pharmaceutical Co Ltd (000919) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.015x

Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million) by net assets (CN¥4.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jinling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
GHCL Limited
NSE:GHCL
 		0.089x
TX Group AG
SW:TXGN
 		0.039x
SNT Dynamics Co Ltd
KO:003570
 		-0.026x
MNTN, Inc.
NYSE:MNTN
 		0.097x
CSN Mineração S.A
SA:CMIN3
 		0.114x
Standard Foods Corp
TW:1227
 		0.080x
CARTER BANKSHARES DL-01
F:6NH
 		N/A
Anyang Iron & Steel Inc
SHG:600569
 		0.195x

Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.85 Billion CN¥154.19 Million 0.032x -26.26%
2023-12-31 CN¥3.68 Billion CN¥158.92 Million 0.043x -39.97%
2022-12-31 CN¥3.63 Billion CN¥260.59 Million 0.072x -13.04%
2021-12-31 CN¥3.53 Billion CN¥292.03 Million 0.083x -8.93%
2020-12-31 CN¥3.43 Billion CN¥311.46 Million 0.091x -33.30%
2019-12-31 CN¥3.42 Billion CN¥465.85 Million 0.136x +1.78%
2018-12-31 CN¥3.25 Billion CN¥433.83 Million 0.134x -7.89%
2017-12-31 CN¥3.05 Billion CN¥443.11 Million 0.145x +360.72%
2016-12-31 CN¥3.05 Billion CN¥96.15 Million 0.031x -56.65%
2015-12-31 CN¥2.92 Billion CN¥212.45 Million 0.073x -33.36%
2014-12-31 CN¥2.75 Billion CN¥299.89 Million 0.109x +3.48%
2013-12-31 CN¥2.57 Billion CN¥271.21 Million 0.105x +11.91%
2012-12-31 CN¥2.47 Billion CN¥232.12 Million 0.094x +26.66%
2011-12-31 CN¥2.33 Billion CN¥172.82 Million 0.074x -8.07%
2010-12-31 CN¥2.20 Billion CN¥177.81 Million 0.081x -11.82%
2009-12-31 CN¥2.05 Billion CN¥188.41 Million 0.092x -43.58%
2008-12-31 CN¥1.88 Billion CN¥305.26 Million 0.162x +168.31%
2007-12-31 CN¥1.95 Billion CN¥118.06 Million 0.061x -25.72%
2006-12-31 CN¥1.70 Billion CN¥138.50 Million 0.082x +16.56%
2005-12-31 CN¥1.56 Billion CN¥109.29 Million 0.070x -35.69%
2004-12-31 CN¥1.47 Billion CN¥159.81 Million 0.109x -7.32%
2003-12-31 CN¥1.38 Billion CN¥161.86 Million 0.117x +11.72%
2002-12-31 CN¥1.24 Billion CN¥130.36 Million 0.105x +26.04%
2001-12-31 CN¥1.11 Billion CN¥92.49 Million 0.083x -61.78%
2000-12-31 CN¥1.06 Billion CN¥231.31 Million 0.218x +458.19%
1999-12-31 CN¥1.02 Billion CN¥39.77 Million 0.039x --